ID-1101

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530101

CAS#: 55399-93-4

Description: ID-1101, also known as Hydroxyisoleucine, is an insulin sensitizer potentially for the treatment of obesity and type 2 diabetes. It is an amino acid extracted from fenugreek seeds, and exhibits an interesting glucose-dependent insulin-stimulating activity, as shown from studies done on rats in vivo.


Chemical Structure

img
ID-1101
CAS# 55399-93-4

Theoretical Analysis

MedKoo Cat#: 530101
Name: ID-1101
CAS#: 55399-93-4
Chemical Formula: C6H13NO3
Exact Mass: 147.09
Molecular Weight: 147.174
Elemental Analysis: C, 48.97; H, 8.90; N, 9.52; O, 32.61

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: ID-1101; 4-OH-Ile; 4OHIle; ID 1101; 4 OH Ile; ID1101

IUPAC/Chemical Name: (2S,3R,4S)-4-Hydroxyisoleucine

InChi Key: OSCCDBFHNMXNME-YUPRTTJUSA-N

InChi Code: InChI=1S/C6H13NO3/c1-3(4(2)8)5(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)/t3-,4-,5-/m0/s1

SMILES Code: N[C@@H]([C@@H](C)[C@@H](O)C)C(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: (2S,3R,4S)-4-Hydroxyisoleucine is an orally active compound isolated from Trigonella foenum-graecum, with anti-diabetes and anti-diabetic nephropathy activity.
In vitro activity: In this study, ELISA was used to determine the effects of 4-HIL (ID-1101) on the levels of TNF-α and MCP-1 (Fig. 4). After 6 h of LPS stimulation, the levels of TNF-α and MCP-1 were reduced by 4-HIL in a dose-dependent (Fig. 4a and d) and time-dependent manner (Fig. 4b and e). Reference: BMC Complement Med Ther. 2020 Dec 9;20(1):373. https://pubmed.ncbi.nlm.nih.gov/33298044/
In vivo activity: Chronic oral administration of 4-HI (ID-1101) at the doses of 50 mg/kg and 100 mg/kg remarkably increased the IGF-1 level in brain homogenate (one-way ANOVA: F(5, 25) = 5.595, p < 0.001) and CSF samples (one-way ANOVA: F(5,25) = 0.971, p < 0.001). Moreover, 4-HI100 mg/kg was more efficient than 4-HI50 mg/kg in restoring the IGF-1 protein level in rat brain homogenate and CSF samples (Figure 10A,B). Reference: Molecules. 2022 Jun 16;27(12):3878. https://pubmed.ncbi.nlm.nih.gov/35745001/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
PBS (pH 7.2) 5.0 33.97
Water 125.0 849.33

Preparing Stock Solutions

The following data is based on the product molecular weight 147.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Zhou C, Chen R, Gao F, Zhang J, Lu F. 4-Hydroxyisoleucine relieves inflammation through iRhom2-dependent pathway in co-cultured macrophages and adipocytes with LPS stimulation. BMC Complement Med Ther. 2020 Dec 9;20(1):373. doi: 10.1186/s12906-020-03166-1. PMID: 33298044; PMCID: PMC7724822. 2. Gao F, Du W, Zafar MI, Shafqat RA, Jian L, Cai Q, Lu F. 4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression. Drug Des Devel Ther. 2015 Oct 20;9:5727-36. doi: 10.2147/DDDT.S92355. PMID: 26527864; PMCID: PMC4621195. 3. Shandilya A, Mehan S, Kumar S, Sethi P, Narula AS, Alshammari A, Alharbi M, Alasmari AF. Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity. Molecules. 2022 Jun 16;27(12):3878. doi: 10.3390/molecules27123878. PMID: 35745001; PMCID: PMC9228431. 4. Mehmood Siddiqui E, Mehan S, Upadhayay S, Khan A, Halawi M, Ahmed Halawi A, Alsaffar RM. Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage. Saudi J Biol Sci. 2021 Nov;28(11):6417-6431. doi: 10.1016/j.sjbs.2021.07.010. Epub 2021 Jul 10. PMID: 34764759; PMCID: PMC8568986.
In vitro protocol: 1. Zhou C, Chen R, Gao F, Zhang J, Lu F. 4-Hydroxyisoleucine relieves inflammation through iRhom2-dependent pathway in co-cultured macrophages and adipocytes with LPS stimulation. BMC Complement Med Ther. 2020 Dec 9;20(1):373. doi: 10.1186/s12906-020-03166-1. PMID: 33298044; PMCID: PMC7724822. 2. Gao F, Du W, Zafar MI, Shafqat RA, Jian L, Cai Q, Lu F. 4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression. Drug Des Devel Ther. 2015 Oct 20;9:5727-36. doi: 10.2147/DDDT.S92355. PMID: 26527864; PMCID: PMC4621195.
In vivo protocol: 1. Shandilya A, Mehan S, Kumar S, Sethi P, Narula AS, Alshammari A, Alharbi M, Alasmari AF. Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity. Molecules. 2022 Jun 16;27(12):3878. doi: 10.3390/molecules27123878. PMID: 35745001; PMCID: PMC9228431. 2. Mehmood Siddiqui E, Mehan S, Upadhayay S, Khan A, Halawi M, Ahmed Halawi A, Alsaffar RM. Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage. Saudi J Biol Sci. 2021 Nov;28(11):6417-6431. doi: 10.1016/j.sjbs.2021.07.010. Epub 2021 Jul 10. PMID: 34764759; PMCID: PMC8568986.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Broca C, Breil V, Cruciani-Guglielmacci C, Manteghetti M, Rouault C, Derouet M, Rizkalla S, Pau B, Petit P, Ribes G, Ktorza A, Gross R, Reach G, Taouis M. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E463-71. PubMed PMID: 15082420.